Achieving crowdfunding goals immediately! 'Reduced Coenzyme Q10 x Assist NMN' sets new goal of 800,000 yen
Key facts
- Achieving crowdfunding goals immediately! 'Reduced Coenzyme Q10 x Assist NMN' sets new goal of 800,000 yen
- Furofushi Institute announced that its health supplement project, 'Reduced Coenzyme Q10 x Assist NMN,' reached its initial 500,000 yen goal early and is now aiming for a next goal of 800,000 yen.
- Source: PR Times
- Date: May 30, 2026
Direct answer
Furofushi Institute announced that its health supplement project, 'Reduced Coenzyme Q10 x Assist NMN,' reached its initial 500,000 yen goal early and is now aiming for a next goal of 800,000 yen.
- Citation
- Achieving crowdfunding goals immediately! 'Reduced Coenzyme Q10 x Assist NMN' sets new goal of 800,000 yen (May 30, 2026), PR Times
- Source
- PR Times
- Date
- May 30, 2026
Furofushi Institute announced that its health supplement project, 'Reduced Coenzyme Q10 x Assist NMN,' reached its initial 500,000 yen goal early and is now aiming for a next goal of 800,000 yen.
📋 Article Processing Timeline
- 📰 Published: May 30, 2026 at 03:48
- 🔍 Collected: May 29, 2026 at 19:08
- 🤖 AI Analyzed: May 29, 2026 at 19:09 (1 min after Collected)
This project was launched with the goal of developing and promoting a supplement combining domestic NMN ('Assist NMN®') and Kaneka's reduced Coenzyme Q10, aiming to provide a new option for supporting a healthy lifespan.
Following the project's launch, the company received significant support and encouragement from many individuals, allowing them to reach the initial goal of 500,000 yen.
The response highlighted a high level of interest in healthy aging and a strong desire among many to continue taking on challenges energetically.
Consequently, Furofushi Institute has set a new next goal of 800,000 yen.
Vision for the 800,000 yen goal
The funds raised through the next goal are planned to be used for:
- Strengthening the stable supply system
- Expanding production capacity to reach more people
- Funding future product development focused on healthy aging
This project is more than just selling supplements; it is an initiative aimed at 'creating a society where people can continue to take on challenges forever.'
Daily health management is the fundamental basis for people to continue working, learning, and challenging themselves as they age. The overwhelming support received reflects the desires of those who wish to live richer lives while maintaining their health.
Furofushi Institute reaffirms that 'staying healthy' is essential to supporting personal freedom and the ability to take on new challenges in life.
About First Innovation's Support
Tsunagari Funding
First Innovation's 'Tsunagari Funding' is a service that connects enterprising businesses with supporters. Beyond simple fundraising, it aims to communicate the passion and social significance behind projects, creating new connections with many people.
For this project, they will continue to broadly communicate the challenges taken on by Furofushi Institute and contribute to increasing awareness regarding the social theme of healthy aging.
FAQ
What is the purpose of the 'Reduced Coenzyme Q10 x Assist NMN' project?
We aim to develop and promote a supplement that combines domestically produced NMN 'Assist NMN®' and Kaneka Corporation's reduced coenzyme Q10 to support healthy longevity.
What is the amount of the next goal for the crowdfunding?
It is 800,000 yen. This was newly set after the initial goal of 500,000 yen was achieved early.
What will the funds collected from the next goal be used for?
The funds are planned to be used for strengthening the stable supply system, expanding the production system, and future product development focused on healthy longevity.
What service is supporting this project?
The crowdfunding support service 'Tsunagari Funding' provided by First Innovation Co., Ltd. is supporting this project.
What are the main business activities of Immortality Research Institute Co., Ltd.?
They provide a comprehensive service that integrates the latest technologies, including research and development for immortality, regenerative medicine, and mental care.